Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
The Medicare agency acknowledges its methodologies to calculate payments are not well-suited to account for the costs and efficiencies of AI software. In its 2022 Physician Fee Schedule proposal out this week, CMS is seeking detailed input to help reform its systems while trying to come up with temporary solutions to provide sufficient reimbursement in the short term.
Getting Wall Street to pay attention to micro- and small-cap companies like PAVmed is difficult, particularly in the medtech field. But with the pending IPO of its Lucid subsidiary and formation of a new one focused on digital health, the company, which has a streamlined model for device innovation, has a near-term opportunity to raise its profile.
CMS dropped its 1,500-page-plus Physician Fee Schedule 2022 proposal July 13. It includes several noteworthy provisions for medtechs.